Decreased Cerebrospinal Fluid Amyloid Beta 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy

Annals of NeurologyVolume 94, Issue 1 p. 205-205 LETTERS/REPLIES Decreased Cerebrospinal Fluid Amyloid Beta 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy Gregor Kuhlenbäumer MD, PhD, Corresponding Author Gregor Kuhlenbäumer MD, PhD [email protected] orcid.org/0000-0002-3262-8113 Department of Neurology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel University (CAU), Kiel, Germany Address correspondence to Dr Kuhlenbäumer, Department of Neurology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel University (CAU), Kiel, Germany. E-mail: [email protected]Search for more papers by this authorUlf Jensen-Kondering MD, Ulf Jensen-Kondering MD orcid.org/0000-0002-0860-4410 Department of Neuroradiology, University Medical Center Schleswig-Holstein, Campus Lübeck, GermanySearch for more papers by this authorNils G. Margraf MPsych, MD, Nils G. Margraf MPsych, MD Department of Neurology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel University (CAU), Kiel, GermanySearch for more papers by this author Gregor Kuhlenbäumer MD, PhD, Corresponding Author Gregor Kuhlenbäumer MD, PhD [email protected] orcid.org/0000-0002-3262-8113 Department of Neurology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel University (CAU), Kiel, Germany Address correspondence to Dr Kuhlenbäumer, Department of Neurology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel University (CAU), Kiel, Germany. E-mail: [email protected]Search for more papers by this authorUlf Jensen-Kondering MD, Ulf Jensen-Kondering MD orcid.org/0000-0002-0860-4410 Department of Neuroradiology, University Medical Center Schleswig-Holstein, Campus Lübeck, GermanySearch for more papers by this authorNils G. Margraf MPsych, MD, Nils G. Margraf MPsych, MD Department of Neurology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel University (CAU), Kiel, GermanySearch for more papers by this author First published: 25 April 2023 https://doi.org/10.1002/ana.26671Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1De Kort AM, Kuiperij HB, Marques TM, et al. Decreased cerebrospinal fluid Abeta 38, 40, 42, and 43 levels in sporadic and hereditary cerebral amyloid angiopathy. Ann Neurol 2023; 93: 1173–1186. 2Margraf NG, Jensen-Kondering U, Weiler C, et al. Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy: new data and quantitative meta-analysis. Front Aging Neurosci 2022; 14:783996. 3McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263–269. Volume94, Issue1July 2023Pages 205-205 ReferencesRelatedInformation